Johnson & Johnson says its COVID-19 vaccine is 85 percent effective at preventing severe disease
Johnson & Johnson has unveiled some highly-anticipated data on its single-shot COVID-19 vaccine.
The company on Friday announced its vaccine candidate in a global trial was found to overall be 66 percent effective at preventing moderate to severe COVID-19, but 85 percent effective at preventing severe disease. In the United States, the company said the level of protection against moderate to severe illness was 72 percent, but in Latin America, it was 66 percent effective. It was also 57 percent effective in South Africa, where most of the COVID-19 cases were from the B.1.351 variant.
Johnson & Johnson's data had been particularly anticipated because, unlike the vaccines from Pfizer and Moderna that have been approved in the United States, this candidate only requires one shot. The overall 66 percent efficacy rate wasn't as high as with either of those vaccines, which were each found to be about 95 percent effective, but that's still above the 50 percent level the FDA requires.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
University of Wisconsin School of Medicine and Public Health vaccine expert Jonathan Temte also told The Washington Post the Johnson & Johnson vaccine could still be a "game changer," especially since it can be stored at refrigerator temperature.
"Back in July and August, I was hoping we would see a vaccine that was 60 percent effective — in my mind, that would be great," Temte told the Post. "And now we have had two that have hit the ball out of the park and set expectations spectacularly high, and that's not fair because we don't need a home run all the times we're up to bat."
Johnson & Johnson also noted that in the the trial, the vaccine provided "complete protection against COVID-related hospitalization and death." The company plans to file with the Food and Drug Administration for emergency authorization within a week, The Associated Press reports, and it says it "expects to have product available to ship immediately following authorization."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.
-
Can Ukraine win over Donald Trump?
Today's Big Question Officials in Kyiv remain optimistic they can secure continued support from the US under a Trump presidency
By Richard Windsor, The Week UK Published
-
Orbital by Samantha Harvey: the Booker prize-winner set to go 'stratospheric'
In The Spotlight 'Bold' and 'scintillating' novel follows six astronauts orbiting Earth on the International Space Station over 24 hours
By Irenie Forshaw, The Week UK Published
-
Gladiator II: Paul Mescal 'mesmerising' in 'relentlessly entertaining' sequel
The Week Recommends Ridley Scott's 'primary aim' is fun, in this 'exhilarating' blockbuster
By Irenie Forshaw, The Week UK Published
-
ACA opens 2025 enrollment, enters 2024 race
Speed Read Mike Johnson promises big changes to the Affordable Care Act if Trump wins the election
By Peter Weber, The Week US Published
-
McDonald's sued over E. coli linked to burger
Speed Read The outbreak has sickened at least 49 people in 10 states and left one dead
By Rafi Schwartz, The Week US Published
-
Texas dairy worker gets bird flu from infected cow
Speed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
By Peter Weber, The Week US Published
-
Dengue hits the Americas hard and early
Speed Read Puerto Rico has declared an epidemic as dengue cases surge
By Peter Weber, The Week US Published
-
US bans final type of asbestos
Speed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
By Peter Weber, The Week US Published
-
Seattle Children's Hospital sues Texas over 'sham' demand for transgender medical records
Speed Read Texas Attorney General Ken Paxton subpoenaed records of any Texan who received gender-affirming care at the Washington hospital
By Peter Weber, The Week US Published
-
Afghanistan has a growing female suicide problem
Speed Read The Taliban has steadily whittled away women's and girls' rights in Afghanistan over the past 2 years, prompting a surge in depression and suicide
By Peter Weber, The Week US Published
-
US life expectancy rose in 2022 but not to pre-pandemic levels
Speed Read Life expectancy is slowly crawling back up
By Devika Rao, The Week US Published